Form 4: Marimed COO Timothy Shaw Reports Routine Equity Vesting and Tax-Related Share Disposition

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, reported the conversion of Restricted Stock Units into common stock and a subsequent sale of shares to cover tax obligations, as part of a routine insider transaction.

Summary

• Timothy Shaw, Chief Operating Officer of Marimed Inc. (MRMD), reported transactions involving company common stock and Restricted Stock Units (RSUs) on June 15, 2025.
• Mr. Shaw converted 81,772 Restricted Stock Units (RSUs) into an equal number of common stock shares.
• Concurrently, 28,335 shares of common stock were withheld by Marimed Inc. to satisfy tax withholding obligations related to the RSU vesting, at a price of $0.0725 per share.
• Following these transactions, Mr. Shaw directly beneficially owns 8,929,361 shares of common stock.
• Additionally, 2,000,000 shares are indirectly beneficially owned by the Shaw Family Trust, though Mr. Shaw disclaims beneficial ownership of these securities.
• Mr. Shaw also holds 163,544 Restricted Stock Units directly, with remaining RSUs scheduled to vest in two equal installments on September 15, 2025, and December 15, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine insider transaction involving RSU vesting and tax withholding, which is an expected part of executive compensation. The executive continues to hold a significant number of shares, indicating ongoing alignment.

Positives

• Vesting of 81,772 Restricted Stock Units indicates compensation realization for the Chief Operating Officer.
• The continued direct beneficial ownership of 8,929,361 common shares by the COO demonstrates significant alignment with shareholder interests.
• Future vesting of 163,544 RSUs on September 15, 2025, and December 15, 2025, provides ongoing incentive for the COO.

Negatives

• A disposition of 28,335 shares of common stock occurred to cover tax withholding obligations, which reduces direct shareholding.

Future Outlook

The document indicates future vesting of 163,544 Restricted Stock Units for Timothy Shaw, with two equal installments scheduled for September 15, 2025, and December 15, 2025, aligning with the terms of an award agreement.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions, common across all publicly traded industries. It reflects standard compensation practices involving equity awards and tax compliance, rather than specific industry trends.

Comparison to Industry Standards

• The RSU vesting and subsequent tax-related share withholding are standard practices for executive compensation in publicly traded companies across various industries.
• The specific volume of shares and the price of the tax-related disposition are particular to Marimed Inc. and Timothy Shaw's compensation structure.
• Without comparable executive compensation data from similar-sized companies in the cannabis or pharmaceutical sectors, a direct comparison of the 'results' is not applicable.
• However, the mechanism of equity compensation and tax handling aligns with general corporate governance and compensation norms.

Related Party Transactions

• The Shaw Family Trust indirectly holds 2,000,000 shares, with the Reporting Person's spouse as trustee and shares for the benefit of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these securities.

Stakeholder Impact

• Shareholders: The report provides transparency regarding executive stock ownership and compensation, which can be viewed positively as it shows alignment of interests. The tax-related sale is a routine event and not indicative of a lack of confidence.

Next Steps

• Remaining Restricted Stock Units (RSUs) will vest in two equal installments on September 15, 2025.
• Remaining Restricted Stock Units (RSUs) will vest in two equal installments on December 15, 2025.

Key Dates

Keywords

Marimed Inc., MRMD, Timothy Shaw, Chief Operating Officer, COO, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Vesting, Tax Withholding, Beneficial Ownership